These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4275983)

  • 21. 5-HIAA in cerebrospinal fluid.
    Coleman M
    Dev Med Child Neurol; 1970 Aug; 12(4):539-41. PubMed ID: 4248085
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunoglobulins in the cerebrospinal fluid in Down's syndrome].
    Bacheschi IC
    Rev Hosp Clin Fac Med Sao Paulo; 1982 Oct; 37(5):212-8. PubMed ID: 6221392
    [No Abstract]   [Full Text] [Related]  

  • 23. 5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test.
    van Praag HM; Korf J
    J Nerv Ment Dis; 1974 May; 158(5):331-7. PubMed ID: 4596091
    [No Abstract]   [Full Text] [Related]  

  • 24. The elimination of 5-hydroxyindoleacetic acid from cerebrospinal fluid: characteristics of the acid transport system of the choroid plexus.
    Sampath SS; Neff NH
    J Pharmacol Exp Ther; 1974 Feb; 188(2):410-4. PubMed ID: 4359553
    [No Abstract]   [Full Text] [Related]  

  • 25. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
    Andersson H; von Essen C; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033
    [No Abstract]   [Full Text] [Related]  

  • 26. 5-Hydroxyindoles in mongolism and hydrocephalus.
    Dubowitz V; Rogers K
    Arch Dis Child; 1969 Dec; 44(238):783. PubMed ID: 4243060
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychological and social development in home-reared children with Down's syndrome (mongolism).
    Cornwell AC; Birch HG
    Am J Ment Defic; 1969 Nov; 74(3):341-50. PubMed ID: 4243399
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnosis of manic-depressive psychosis from cerebrospinal fluid concentration of 5-hydroxyindoleacetic acid.
    Sjöström R
    Adv Biochem Psychopharmacol; 1974; 11(0):369-75. PubMed ID: 4845705
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative mortality in mentally retarded patients in California, with and without Down's syndrome, 1986-1991.
    Singer RB; Strauss D
    J Insur Med; 1997; 29(3):172-84. PubMed ID: 10176367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose tolerance in Down's syndrome.
    Sutnick AI; London WT; Gerstley BJ; Coyne VE; Blumberg BS; Lustbader ED
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):471-80. PubMed ID: 4277496
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of probenecid on free 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and its sulphate in human cerebrospinal fluid.
    Gordon EK; Oliver J; Goodwin FK; Chase TN; Post RM
    Neuropharmacology; 1973 Apr; 12(4):391-6. PubMed ID: 4703880
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychomotor activity, sleep, and biogenic amine metabolites in depression.
    Weiss BL; Kupfer DJ; Foster FG; Delgado J
    Biol Psychiatry; 1974 Aug; 9(1):45-54. PubMed ID: 4376024
    [No Abstract]   [Full Text] [Related]  

  • 33. 5-hydroxytryptophan (5-HTP) in Down's syndrome.
    Partington MW; MacDonald MR
    Dev Med Child Neurol; 1971 Jun; 13(3):362-72. PubMed ID: 4255254
    [No Abstract]   [Full Text] [Related]  

  • 34. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM; Banasiak K
    Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
    Carratelli M; Porcaro L; Ruscica M; De Simone E; Bertelli AA; Corsi MM
    Int J Clin Pharmacol Res; 2001; 21(2):79-84. PubMed ID: 11824651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of the chronic treatment with L-acetylcarnitine in Down's syndrome].
    De Falco FA; D'Angelo E; Grimaldi G; Scafuro F; Sachez F; Caruso G
    Clin Ter; 1994 Feb; 144(2):123-7. PubMed ID: 8181206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular health status of subjects with Down's syndrome in Benin City, Nigeria.
    Ebeigbe JA; Akpalaba R
    Afr J Med Med Sci; 2006 Sep; 35(3):365-8. PubMed ID: 17312746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steady-state levels of probenecid and their relation to acid monoamine metabolites in human cerebrospinal fluid.
    Sjöström R
    Psychopharmacologia; 1972; 25(1):96-100. PubMed ID: 4261043
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of L-tryptophan administration on the concentration of probenecid in plasma and cerebrospinal fluid in patients.
    Dunner DL; Heiber S; Perel JM
    Psychopharmacology (Berl); 1977 Aug; 53(3):305-8. PubMed ID: 408860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of effect of para-chlorophenylalanine on 5-hydroxyindoleacetic acid in cerebrospinal fluid in man.
    Sjöström R
    Psychopharmacologia; 1972; 27(4):393-6. PubMed ID: 4265209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.